Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Patient Education Materials for Non-English Speakers

Katie Robinson  |  Issue: July 2023  |  July 10, 2023

Recently, the Vasculitis Foundation, in collaboration with a group of physicians and vasculitis investigators in the U.S. and Latin America (i.e., Mexico, Colombia, Peru, Chile and Argentina), launched an educational series of videos in Spanish called, Aprendiendo de Vasculitis.

“The goal of these videos is to provide education to all Spanish-speaking patients,” explains Sebastian E. Sattui, MD, MS, an assistant professor of medicine and director of the UPMC Vasculitis Center at the University of Pittsburgh School of Medicine.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

This initial video series includes the following topics:

  • What is vasculitis?
  • Creating your medical team;
  • Glucocorticoids;
  • Medications used for the treatment of vasculitis;
  • What is remission?
  • Dealing with damage caused by vasculitis and complications from treatment; and
  • Patient’s perspective of living with vasculitis.

    Dr. Sattui

“The goal was to cover basic topics that are relevant to the care of patients living with vasculitis, understanding that most patient-directed information is in English,” Dr. Sattui says. The videos are available in the patient education section of the Vasculitis Foundation, as well as on YouTube.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“Dissemination of these videos and materials has been done through all social media channels of the Vasculitis Foundation; local patient organizations in South America, with special support from Vasculitis Chile; and the Pan American League of Rheumatology Associations (PANLAR),” Dr. Sattui says.

The Vasculitis Foundation is also translating its vasculitis disease-specific brochures into Spanish.

Local organizations in Latin America and Spain also have activities to provide information to patients, but most of these organizations tend to point their patients to the resources at the Vasculitis Foundation because it is “one of the largest and most established patient organizations for people living with vasculitis,” Dr. Sattui says.

“Previous efforts have been primarily focused on specific sessions or webinars by existing patient groups. The goal of this series is to create patient friendly resources that will permanently be accessible to all patients,” he adds.

Other Sources

Other reputable sources for patient education videos and materials in languages other than English include the ACR, the Lupus Foundation of America and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). Print materials on the diagnosis, treatment and prevention of a range of health conditions related to arthritis, musculoskeletal, and skin diseases are available through NIAMS in English, Spanish, Chinese, Korean and Vietnamese. NIAMS also provides social media resources aimed at helping people take steps to improve their health.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:Patient PerspectivePractice Management Tagged with:health literacypatient education

Related Articles
    Hanna Kuprevich / shutterstock.com

    How to Help Your Patients Find Credible Information about Their Disease

    May 17, 2019

    Where can patients obtain more information about their diagnoses and prescription drugs, and answers to the assortment of questions they have about living with a chronic disease once they leave the rheumatologist office? Patient education materials can be found in many places on the internet, but those looking for answers may need a helping hand…

    Fall 2021’s Awards, Appointments & Announcements in Rheumatology

    October 13, 2021

    Jeffrey Siegel, MD, Assumes New Position as Director for New Office of Drug Evaluation Sciences at the FDA On Feb. 16, Jeffrey Siegel, MD, became the director of the recently created Office of Drug Evaluation Sciences at the U.S. Food & Drug Administration (FDA). The move, he says, “puts together many of the different things…

    How Rheumatologists Can Boost Patient Understanding of Educational Materials

    April 2, 2014

    Choosing appropriate, pre-written disease fact sheets, or writing your own educational documents can help patients with low health literacy comprehend information about their condition

    ilusmedical / shutterstock.com

    The State of Clinical Research in Vasculitis: 2021

    January 19, 2021

    It is an exciting time in the world of vasculitis research. More clinical studies and trials are being conducted now than at any time in history. In the past ten years, four drugs have been approved by the U.S. Food & Drug Administration (FDA) and other regulatory agencies specifically for the treatment of vasculitis: Rituximab…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences